Jabak Visited Marjayoun Hospital To Improve The Health Services And Conditions Of The Governmental H

Jabak Visited Marjayoun Hospital to Improve the Health Services and Conditions of the Governmental Hospitals in Disadvantaged Areas

Minister of Public Health Dr. Jamil Jabak visited Marjayoun Governmental Hospital in Jdeidet Marjayoun to improve the health care and medical services in Marjayoun District, completing his tour of governmental hospitals in the disadvantaged areas.

Jabak toured the hospital’s departments with the chairman of the board of directors and the director general Dr. Moueness Kalakech who briefed him on the medical services the hospital provides to the citizens coming from different villages in South Lebanon. Dr. Kalakech also informed Minister Jabak of the needs of the hospital as to the medical equipment. Jabak met with a number of patients in the hospital and visited the intensive care and cardiology departments.

Jabak then visited the new building that was constructed in 2016 before he held a press conference in Kalakech’s Office at the hospital.
“Marjayoun Hospital is an example of coexistence. Although it is a small hospital with 60 beds only, however it has great potential and highly qualified doctors,” Jabak stated.

The Hospital’s Director Dr. Moueness Kalakech briefed Minister Jabak on the medical services provided by Marjayoun Hospital, praising the major role of Speaker Nabih Berri and his support to the hospital.

...

150

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M05BA08	ZOLEDRO-DENK	G	Zoledronic acid - 4mg/5ml	4mg/5ml	Injectable concentrate for solution	4,388,990 L.L
M05BA08	ZOLEDRONIC ACID ACCORD	G	Zoledronic acid - 4mg/5ml	4mg/5ml	Injectable concentrate for solution	7,028,741 L.L
R05CB02	BROMHEXINE	G	Bromhexine - 4mg/5ml	4mg/5ml	Elixir	176,619 L.L
M05BA08	ZOLEDRO-DENK	G	Zoledronic acid - 4mg/5ml	4mg/5ml	Injectable concentrate for solution	L.L
A04AA01	NAUSETRON	G	Ondansetron - 4mg/5ml	4mg/5ml	Solution	958,608 L.L
A04AA01	NAUSETRON	G	Ondansetron - 4mg/5ml	4mg/5ml	Solution	802,466 L.L
A04AA01	ONDEMED	G	Ondansetron (HCl) - 4mg/5ml	4mg/5ml	Solution	858,779 L.L
A04AA01	ONZO	G	Ondansetron (HCl dihydrate) - 4mg/5ml	4mg/5ml	Solution	1,283,370 L.L
A04AA01	VOMITRON	G	Ondansetron (HCl) - 4mg/5ml	4mg/5ml	Solution	858,779 L.L
A04AA01	VOMITRON	G	Ondansetron (HCl) - 4mg/5ml	4mg/5ml	Solution	304,604 L.L
D06BA02	CREM-O-SULFA	G	Sulfathiazole - 5%	5%	Cream	202,216 L.L
D06BB03	CIVAR	G	Aciclovir - 5%	5%	Cream	507,972 L.L
D06BB10	ALDARA	B	Imiquimod - 5%	5%	Cream	6,301,277 L.L
D06BB10	GENIMOD	G	Imiquimod - 5%	5%	Cream	2,268,406 L.L
D06BB10	JEDARA	G	Imiquimod - 5%	5%	Cream	3,850,109 L.L
J06BA02	IMMUNOREL	BioHuman	Human normal immunoglobulin - 5g/100ml	5%	Injectable solution	L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	159,736 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	179,272 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	208,002 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	224,090 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L

...

150

...